Thursday 22 June 2023
12:00-13:30 (CEST)
Background
The global research agenda for AMR in human health aims to catalyze research on the burden and impact of AMR, strategies to prevent infections and development of resistance, the discovery and development of new diagnostics and better treatment regimens, and how to optimize the use of current tools and implement them more efficiently. Ultimately, it aims to inform evidence-based policies and interventions to strengthen the AMR response, especially in low-and-middle-income countries (LMICs).
The research agenda was developed following a rigorous and transparent process starting with a scoping review of over 3,000 documents in the past 10 years which generated 2,340 knowledge gaps. Following several rounds of review and consolidation of these knowledge gaps into research questions, over 230 experts globally across a range of disciplines related to AMR research scored the questions against five criteria in a transparent, independent and reproducible approach. This enabled the identification of global AMR research priorities for human health by 2030.
Agenda
- Opening remarks: Dr Hanan Balkhy, Assistant Director-General, Antimicrobial Resistance Division, WHO
- The global research agenda for AMR: priorities for research in human health by 2030: Dr Silvia Bertagnolio, Unit Head, Antimicrobial Resistance Division, WHO
- Commentary and reflections from speakers:
- Priorities for research on resistant tuberculosis: Professor Claudia M. Denkinger, Head of Division of Infectious Disease and Tropical Medicine, Heidelberg University Hospital (UKHD), Germany
- Prevention of infections: Dr Tochi Okwor, Chair Nigeria Antimicrobial Resistance Coordination Committee (AMR) and Infection Prevention and Control (IPC) Programme Coordinator, Nigeria Centre for Disease Control and Prevention
- Diagnosis of bacterial infections: Professor Till Bachmann, Professor and Chair of Molecular Diagnostics and Infection, University of Edinburgh, United Kingdom
- Treatment and care: Professor Céline Pulcini, Université de Lorraine - CHRU Nancy, France
- Priorities for research on critical fungi: Professor Nelesh Govender, National Institute for Communicable Diseases and University of the Witswatersrand (WHO CC for AMR), South Africa, and Dr Ana Alastruey-Izquierdo, Instituto de Salud Carlos III, Spain
- Translating research into action: Laura Marin, Head of Secretariat, European Commission Joint Programming Initiative on Antimicrobial Resistance, Swedish Research Council, Coordinator CSA DESIGN OH AMR; Dr Alexander Pym, Director of Infectious Disease, Wellcome Trust
- Closing remarks: Professor Sabiha Essack, School of Pharmaceutical Sciences at the University of KwaZulu-Natal
- The session was moderated by Professor Sabiha Essack
Interpretation was available in French and Spanish.